HUM
Humana Inc.
$378.73
장중 · Vol 13.2K · 52주 $163.11–$428.88 · 기준 2026. 8. 21. PM 3:59 ET
일봉 $385.98 · Aug 31, 2026
HUM 가격 추세
종가
$385.98
시가
$385.36
고가
$386.76
저가
$383.01
30초 브리핑
HUM 오늘의 판단 요약
보유 데이터를 비교 가능한 문장으로 해석한 요약입니다.
52주 범위의 81%
연중 고점권입니다. 추세 강도와 돌파 실패 위험을 함께 확인하세요.
Forward P/E 23.1배
선행 P/E가 낮아 시장은 이익 증가를 반영하고 있습니다.
20일 평균의 1.5배
평소보다 거래가 활발해 가격 움직임의 확인 강도가 높습니다.
2026-11-06
실적 전후 변동성 확대 가능성이 있으므로 컨센서스 범위와 옵션 기대변동을 함께 보세요.
펀더멘털 기준 Sep 1, 2026 · 규칙 기반 요약이며 투자 조언이 아닙니다.
핵심 통계
HUM 일봉·펀더멘털 스냅샷 기준 주요 지표
펀더멘털 스냅샷 Sep 1, 2026
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Humana Building · Louisville, KY, United States · 직원 67,060명
시가총액
$46.02B
Trailing P/E
36.5
최근 12개월 이익 기준
Forward P/E
23.1
이익 증가 기대 반영
EPS (TTM)
$10.56
배당 수익률
0.92%
배당성향
33.5%
베타
0.74
시장보다 방어적
ROE
6.9%
P/B
2.40
EV/EBITDA
10.4
52주 범위
$163.11 – $428.88
현재 위치 81%
거래량
1.12M
20일 평균 728.1K · 1.5배
애널리스트 의견
매수 46%
총 26명 · 0m
DITM LEAPS Analysis
HUM 장기 DITM 콜옵션을 진입 적합도 순으로 비교
| Contract | Expiry | Strike | Price | Lev. | Delta | Extrinsic | Spread | IV | OI | Score | 상세 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HUM280121C00200000 | 1/21/28 · 1.4Y | $200.00 | $203.50 | 1.7x | 0.9094 | 10.0% | 4.42% | 62.40% | 291 | 77.38 | |
| HUM280121C00210000 | 1/21/28 · 1.4Y | $210.00 | $196.50 | 1.8x | 0.8983 | 11.8% | 4.58% | 62.23% | 264 | 74.75 | |
| HUM280121C00195000 | 1/21/28 · 1.4Y | $195.00 | $211.50 | 1.6x | 0.9070 | 11.0% | 4.26% | 67.93% | 151 | 74.67 | |
| HUM280121C00220000 | 1/21/28 · 1.4Y | $220.00 | $189.50 | 1.8x | 0.8872 | 13.9% | 4.75% | 61.85% | 133 | 71.54 | |
| HUM280121C00230000 | 1/21/28 · 1.4Y | $230.00 | $182.40 | 1.8x | 0.8760 | 16.0% | 5.04% | 61.19% | 120 | 68.94 | |
| HUM280121C00250000 | 1/21/28 · 1.4Y | $250.00 | $168.50 | 1.9x | 0.8526 | 20.9% | 5.34% | 59.75% | 508 | 65.17 | |
| HUM280121C00240000 | 1/21/28 · 1.4Y | $240.00 | $175.50 | 1.9x | 0.8643 | 18.4% | 5.13% | 60.58% | 23 | 64.69 | |
| HUM280121C00260000 | 1/21/28 · 1.4Y | $260.00 | $161.75 | 2.0x | 0.8402 | 23.8% | 5.26% | 59.04% | 42 | 59.94 | |
| HUM280121C00270000 | 1/21/28 · 1.4Y | $270.00 | $155.50 | 2.0x | 0.8271 | 27.2% | 5.79% | 58.62% | 61 | 57.02 | |
| HUM280121C00280000 | 1/21/28 · 1.4Y | $280.00 | $149.50 | 2.1x | 0.8137 | 30.9% | 6.02% | 58.26% | 38 | 53.13 | |
| HUM280121C00290000 | 1/21/28 · 1.4Y | $290.00 | $143.50 | 2.1x | 0.8000 | 35.0% | 6.27% | 57.78% | 27 | 49.28 | |
| HUM280121C00300000 | 1/21/28 · 1.4Y | $300.00 | $142.00 | 2.1x | 0.7846 | 41.4% | 5.63% | 60.38% | 86 | 44.96 | |
| HUM280121C00310000 | 1/21/28 · 1.4Y | $310.00 | $132.00 | 2.2x | 0.7718 | 44.5% | 6.06% | 56.85% | 17 | 41.42 | |
| HUM280121C00320000 | 1/21/28 · 1.4Y | $320.00 | $130.50 | 2.2x | 0.7571 | 51.5% | 6.90% | 59.07% | 19 | 35.55 |
재무제표
HUM 연간 손익·현금흐름·재무상태
매출 성장률
+10.1%
최근 연간 YoY
EPS 성장률
-1.4%
최근 연간 YoY
영업이익률
1.7%
최근 연간
FCF 마진
0.3%
잉여현금흐름 / 매출
매출 추세
순이익 추세
잉여현금흐름 추세
| 항목 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| 매출 | $129.66B+10.1% | $117.76B+10.7% | $106.37B+14.5% | $92.87B |
| 매출총이익 | — | — | — | — |
| 영업이익 | $2.19B-8.2% | $2.38B-38.6% | $3.88B-2.3% | $3.97B |
| 순이익 | $1.19B-1.6% | $1.21B-51.5% | $2.49B-11.3% | $2.81B |
| 희석 EPS | $9.84-1.4% | $9.98-50.1% | $20.00-9.4% | $22.08 |
| EBITDA | — | — | — | — |
| 영업현금흐름 | $921.00M-68.9% | $2.97B-25.5% | $3.98B-13.2% | $4.59B |
| 잉여현금흐름 | $375.00M-84.3% | $2.39B-19.7% | $2.98B-13.7% | $3.45B |
| 총자산 | $48.91B+5.2% | $46.48B-1.2% | $47.06B+9.3% | $43.05B |
| 총부채 | $12.37B+5.5% | $11.72B+0.6% | $11.66B+4.8% | $11.13B |
최신 연도 우선 · 작은 퍼센트는 직전 연도 대비 변화입니다.
캘린더
HUM 실적·배당 일정
매출 하단
$40.43B
EPS 하단
$-1.14
매출 상단
$41.44B
배당 지급일
2026-07-31
32일 전
실적 발표일
2026-11-06
D-66
EPS 상단
$0.47
매출 컨센서스
$40.88B
EPS 컨센서스
$-0.94
배당락일
2026-06-26
67일 전
최근 배당
| 배당락일 | 주당 배당 |
|---|---|
| Jun 26, 2026 | $0.8850 |
| Mar 27, 2026 | $0.8850 |
| Dec 26, 2025 | $0.8850 |
| Sep 26, 2025 | $0.8850 |
| Jun 27, 2025 | $0.8850 |
| Mar 28, 2025 | $0.8850 |
| Dec 31, 2024 | $0.8850 |
| Sep 30, 2024 | $0.8850 |
뉴스
HUM 관련 최신 기사
실적UNH Stock Gets Cheaper Only If The Margins Come Back
Consensus knocks a quarter off the health insurer's earnings multiple over two years, part of it measurement, and almost none of it from selling more coverage.
Trefis · Aug 31, 2026
일반Humana Is Cutting Medicare Advantage Plans for 2027. The Non-Renewal Letters Arrive in Early October.
A non-renewal notice from Humana can feel like bad news, but buried inside federal Medicare rules is a protection that most long-time Advantage members have no idea they still qualify for.
24/7 Wall St. · Aug 30, 2026
제품·기술Is CVS Stock Set for a Rebound?
Its market-shock drawdowns have been ordinary in depth, and some of its longest waits back to the old high came after falls the index barely noticed.
Trefis · Aug 28, 2026
일반CVRx Secures Devoted Health Coverage for Barostim Therapy
CVRX secures Devoted Health Medicare Advantage coverage for Barostim, expanding reimbursement access to about 466,000 members across 29 states.
Zacks · Aug 28, 2026
실적Why Is Humana (HUM) Up 7.1% Since Last Earnings Report?
Humana (HUM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks · Aug 28, 2026
일반Can a $68 Billion Payout Save UNH Stock?
The healthcare giant sent a fortune back to its owners, but the market yawned. Here’s the real accounting of what that cash bought, and what it didn't.
Trefis · Aug 27, 2026
일반2 S&P 500 Stocks with Competitive Advantages and 1 That Underwhelm
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.
StockStory · Aug 27, 2026
- 제품·기술
Humana-owned Villages Health agrees to $542M settlement for overbilling Medicare
The Central Florida provider manufactured fake diagnosis codes for its Medicare Advantage patients from 2020 to 2024, the DOJ said. Humana bought The Villages Health last year.
Healthcare Dive · Aug 27, 2026
제품·기술Here's Why Investors Should Retain Humana Stock for Now
HUM benefits from Medicare Advantage growth, CenterWell expansion and strong cash generation, but rising costs and debt remain concerns.
Zacks · Aug 26, 2026
일반DVA & Humana Expand Value-Based Care for Kidney Disease Patients
DaVita expands its Humana partnership to earlier-stage kidney disease, bringing value-based care to over 10,000 Medicare Advantage members.
Zacks · Aug 26, 2026
홀더
HUM 내부자·기관 보유 현황
최신 보고 목록 기준이며 실제 거래 시점과 보고일 사이에는 시차가 있습니다.
기관 보유
101.0%
기관 보유 (유동주식)
101.2%
내부자 보유
0.2%
기관 수
1,310
주요 기관 홀더
| 홀더 | 주식 수 | 평가액 | 지분 | 변동 | 보고일 |
|---|---|---|---|---|---|
| Dodge & Cox Inc. | 10.94M | $4.19B | 9.1% | -3.9% | Jun 30, 2026 |
| Blackrock Inc. | 10.42M | $3.99B | 8.7% | 2.1% | Jun 30, 2026 |
| Vanguard Capital Management LLC | 7.84M | $3.01B | 6.5% | 0.1% | Jun 30, 2026 |
| Vanguard Portfolio Management LLC | 5.82M | $2.23B | 4.8% | 0.2% | Jun 30, 2026 |
| State Street Corporation | 5.46M | $2.09B | 4.5% | 0.1% | Jun 30, 2026 |
| Pzena Investment Management LLC | 4.40M | $1.69B | 3.7% | -19.5% | Jun 30, 2026 |
| Eagle Capital Management LLC | 3.85M | $1.47B | 3.2% | 29.6% | Jun 30, 2026 |
| Sessa Capital IM, L.P. | 3.73M | $1.43B | 3.1% | 0.0% | Jun 30, 2026 |
| Massachusetts Financial Services Co. | 3.58M | $1.37B | 3.0% | -20.2% | Jun 30, 2026 |
| Geode Capital Management, LLC | 3.37M | $1.29B | 2.8% | 1.3% | Jun 30, 2026 |
면책조항: 증시가격은 모든 주식 시장의 최신 증시가격을 표시하는 것은 아니며, 정보가 지연되거나 잘못될 수 있습니다. 거래 목적이나 조언이 아닌 정보 제공 목적으로만 제공됩니다.
.png&w=3840&q=75)
![[일간 리포트] 2026년 매크로 전환점: AI 자본 지출의 역설과 미국 소비 절벽 분석(2026.02.11)](/_next/image?url=%2Fuploads%2F1770766346972_unnamed_(27).png&w=3840&q=75)
![[일간 리포트] 연준의 균열(10:2)과 AI Capex의 딜레마 (MSFT vs META)(2026.01.29)](/_next/image?url=%2Fuploads%2F1769642347461_unnamed_(19).png&w=3840&q=75)